Back

Time to use SGLT2-inhibitors in cardio-oncology? - discussion

20 June 2026 (09:15 - 09:30)
Organised by: Logo
Congress Presentation Part of: Time to use SGLT2-inhibitors in cardio-oncology? Cardio-Oncology Delegates Premium Access ESC Cardio-Oncology 2026 Council of Cardio-Oncology

3 More presentations in this session

Presentation thumbnail
SGLT2 inhibitors in cardio-oncology: translational evidence
Professor B. Ibanez (Madrid, ES)
Slides Video
Presentation thumbnail
Time to use SGLT2-inhibitors in cardio-oncology? - pro
Professor V. Vassiliou (Norwich, GB)
Slides Video
Presentation thumbnail
Time to use SGLT2-inhibitors in cardio-oncology? - con
Doctor A. Nohria (New York, US)
Slides Video

Access the full session

Session thumbnail
Time to use SGLT2-inhibitors in cardio-oncology?
Video

The Event

Event poster

ESC Cardio-Oncology 2026

20 June 2026 09:15 CET
You may be interested in
thumbnail
Congress Session
Time to use SGLT2-inhibitors in cardio-oncology?
thumbnail
Congress Presentation
Indications for SGLT2i to prevent cardiovascular toxicity
thumbnail
Congress Presentation
Time to use SGLT2-inhibitors in cardio-oncology? - con

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources